India’s Covaxin effectively neutralises Delta variant of COVID-19, says NIH
The NIH said results of two studies of blood serum from people who had received Covaxin suggest that the vaccine generates antibodies that effectively neutralise the B.1.1.7 (Alpha) and B.1.617 (Delta) variants of SARS-CoV-2, first identified in the UK and India, respectively.
India supports dialogue and diplomacy, not war: PM Modi at BRICS Summit
BRICS adopts Kazan Declaration
Operation Herof: The changing landscape of Baloch resistance
Yerevan Dialogue: Sustainable peace in the South Caucuses very much possible, says Armenian PM Pashinyan
What is Happening to Religious Minorities in Bangladesh After the Resignation of Sheikh Hasina?